Speaker

Josh Mendell, The University of Texas Southwestern Medical Center, USA

Dr. Joshua Mendell attained his undergraduate degree in Biology at Cornell University in 1996 and completed an M.D.-Ph.D degree at Johns Hopkins in 2003.  In 2004, Dr. Mendell established a research group at Johns Hopkins focused on the post-transcriptional regulation of gene expression and the roles of such pathways in normal physiology and in diseases such as cancer.  In particular, the Mendell laboratory has devoted significant effort towards elucidating functions of the microRNA (miRNA) pathway.  Dr. Mendell’s research group provided one of the first demonstrations that miRNAs are functional components of critical oncogenic and tumor suppressor pathways and that miRNAs represent potent and non-toxic anti-cancer therapeutic agents when delivered systemically.  Dr. Mendell has been the recipient of several awards including being named the Outstanding Young Scientist in the State of Maryland in 2007 and a HHMI Early Career Scientist in 2009.  In 2010, Dr. Mendell received the AACR Award for Outstanding Achievement in Cancer Research.  In 2011, Dr. Mendell received a Rising Stars Award from the Cancer Prevention and Research Institute of Texas and relocated his laboratory to UT Southwestern Medical Center in Dallas.

« Go Back